NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 153 filers reported holding NOVAVAX INC in Q1 2018. The put-call ratio across all filers is 1.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $77,000 | -70.3% | 140,500 | 0.0% | 0.00% | -70.0% |
Q4 2018 | $259,000 | -1.9% | 140,500 | 0.0% | 0.01% | +11.1% |
Q3 2018 | $264,000 | +95.6% | 140,500 | +39.8% | 0.01% | +80.0% |
Q2 2018 | $135,000 | +6.3% | 100,500 | +66.1% | 0.01% | 0.0% |
Q1 2018 | $127,000 | +71.6% | 60,500 | +0.8% | 0.01% | +66.7% |
Q4 2017 | $74,000 | +8.8% | 60,000 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $68,000 | -9.3% | 60,000 | +485.1% | 0.00% | -25.0% |
Q2 2016 | $75,000 | +41.5% | 10,255 | 0.0% | 0.00% | +33.3% |
Q1 2016 | $53,000 | -37.6% | 10,255 | +1.8% | 0.00% | -25.0% |
Q4 2015 | $85,000 | -39.3% | 10,069 | -57.1% | 0.00% | -60.0% |
Q4 2014 | $140,000 | +180.0% | 23,497 | +106.3% | 0.01% | +150.0% |
Q3 2014 | $50,000 | – | 11,390 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
Bellevue Group AG | 325,000 | $410,000 | 0.08% |
Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |